- IP hearings this week
- IP trials
- IP Judicial review hearings
- IP appeals at the Federal Court of Appeal
(As published on the Federal Court and Federal Court of Appeal websites on Dec 14, 2018 at 03:02:00)
This week in IP
| Date | File No. | Type | Name | Location | Length |
| Dec 17, 2018 | T-1270-17 | CMC | Pfizer Canada Inc V. Genentech, Inc (Patent - Pertuzumab*) | Ottawa | 1 h |
| Dec 17, 2018 | T-401-18 | CMC | Hoffmann-la Roche Limited Et Al V. Pfizer Canada Inc. (Patent - Trastuzumab*) | Ottawa | 1 h |
| Dec 17, 2018 | T-869-17 | CMC | Pfizer Canada Inc. V. Genentech, Inc. (Patent - Trastuzumab*) | Ottawa | 1 h |
| Dec 17, 2018 | T-876-17 | CMC | Pfizer Canada Inc. V. Genentech Inc. (Patent - Trastuzumab*) | Ottawa | 1 h |
| Dec 17, 2018 | T-1143-17 | CMC | Celgene Inc. Et Al V. Dr. Reddy's Laboratories Ltd. Et Al (Patent - Lenalidomide*) | Toronto | 30 m |
| Dec 17, 2018 | T-1669-17 | CMC | Celgene Inc. Et Al V. Dr. Reddy's Laboratories Ltd. Et Al (Patent - Lenalidomide*) | Toronto | 30 m |
| Dec 17, 2018 | T-1692-18 | CMC | Cubist Pharmaceuticals Llc Et Al V. Teva Canada Limited (Patent - Daptomycin*) | Ottawa | 1 h |
| Dec 18, 2018 | T-1636-18 | M | Depura Partners Llc's V. Desjardins General Insurance Inc. Et Al (Patent) | Montréal | 2 h |
| Dec 18, 2018 | T-1831-16 | CMC | Edwards Lifesciences Pvt, Inc. Et Al. V. Livanova Canada Corp., Et Al. (Patent) | Toronto | 30 m |
| Dec 18, 2018 | T-330-16 | M | Richard Ivey School Of Business Foundation V. Shih-fen S. Chen (Copyright) | Ottawa | 3 h |
| Dec 18, 2018 | T-458-17 | CMC | Rallysport Direct Llc V. 2424508 Ontario Ltd Et Al. (Copyright) | Ottawa | 1 h |
| Dec 18, 2018 | T-913-17 | CMC | Canadian National Railway Company V. Bnsf Railway Company (Patent) | Ottawa | 1 h |
| Dec 18, 2018 | T-1034-17 | CMC | Endo Ventures Ltd. Et Al V. Apotex Inc. Et Al (Patent - Tapentadol*) | Ottawa | 1 h |
| Dec 19, 2018 | T-2004-13 | CMC | Sanofi Et Al V. Sandoz Canada Inc. (Patent - Clopidogrel*) | Toronto | 30 m |
| Dec 19, 2018 | T-2009-13 | CMC | Sanofi Et Al V. Pharmascience Inc. Et Al (Patent - Clopidogrel*) | Toronto | 30 m |
| Dec 20, 2018 | T-1203-18 | CMC | Sandpiper Distributing Inc. V. Zacharias Ringas Et Al. (Trade Mark) | Ottawa | 1 h |
| Dec 20, 2018 | T-896-15 | CMC | Georgetown Rail Equipment Company V. Rail Radar Inc. Et Al (Patent) | Toronto | 30 m |
| Dec 20, 2018 | T-846-18 | M | Red Wing Shoe Company, Inc. Et Al V. Ralph Graeme Hill Et Al (Trade Mark) | Toronto | 3 h |
| Dec 20, 2018 | T-929-18 | CMC | Galderma Canada Inc., Et Al. V. Apotex Inc. (Patent - Doxycycline*) | Ottawa | 1 h |
Return to top.
Scheduled IP Trials
| Date | File No. | Name | Location | Length |
| Feb 4, 2019 | T-1930-13 | Tensar Technologies Ltd Et Al V. Enviro-pro Geosynthetics Ltd. (Patent) | Montréal | 10 d |
| Mar 11, 2019 | T-1612-16 | Aux Sable Liquid Products Lp Et Al. V. Jl Energy Transportation Inc. (Patent) | Calgary | 10 d |
| Apr 1, 2019 | T-1231-17 | Spin Master Ltd V. Mattel Canada Inc. (Patent) | Toronto | 10 d |
| May 6, 2019 | T-816-17 | Rosseau Asset Management Ltd V. The Rosseau Group Inc Et Al (Trade Mark) | Toronto | 5 d |
| May 6, 2019 | T-548-18 | Loblaws Inc. V. Columbia Insurance Company Et Al (Trade Mark) | Toronto | 5 d |
| Jun 4, 2019 | T-320-17 | Prévost Fortin D'aoust S.e.n.c.r.l. C. Pfd Notaires, S.e.n.c.r.l. Et Al (Trade Mark) | Montréal | 3 d |
| Jul 8, 2019 | T-346-17 | Icon Elite Group Inc. V. Blue Sports Import-export Inc. Et Al (Patent) | Montréal | 5 d |
| Sep 9, 2019 | T-1969-17 | Genentech, Inc. Et Al. V. Celltrion Healthcare Co., Ltd. (unknown - Trastuzumab*) | Toronto | 10 d |
| Sep 9, 2019 | T-1970-17 | Genentech, Inc. Et Al V. Celltrion Healthcare Co., Ltd. (unknown - Trastuzumab*) | Toronto | 10 d |
| Sep 9, 2019 | T-1971-17 | Genentech, Inc. Et Al V. Celltrion Healthcare Co., Ltd (unknown - Trastuzumab*) | Toronto | 10 d |
| Sep 16, 2019 | T-633-18 | Nutramax Laboratories, Inc. V. Aventix Animal Health Corporation (Patent) | Ottawa | 5 d |
| Sep 30, 2019 | T-396-13 | Hospira Healthcare Corporation V. The Kennedy Institute Of Rheumatology (Patent - Infliximab*) | Toronto | 10 d |
| Sep 30, 2019 | T-353-18 | Janssen Inc. Et Al V. Teva Canada Limited (Patent - Paliperidone*) | Toronto | 10 d |
| Oct 21, 2019 | T-608-17 | Seedlings Life Science Ventures,llc V. Pfizer Canada Inc. (Patent) | Ottawa | 15 d |
| Oct 21, 2019 | T-783-17 | Palos Verdes Building Corp. V. Rozon Batteries Inc. (Trade Mark) | Ottawa | 10 d |
| Oct 21, 2019 | T-1280-14 | Marlboro Canada Limited Et Al V. Philip Morris Brands Sarl Et Al (Trade Mark) | Montréal | 20 d |
| Oct 28, 2019 | T-301-16 | Wi-lan Inc. V. Telus Corporation Et Al. (Patent) | Toronto | 30 d |
| Oct 28, 2019 | T-303-16 | Wi-lan Inc. V. Bell Mobility Inc. (Patent) | Toronto | 30 d |
| Oct 28, 2019 | T-304-16 | Wi-lan Inc. V. Rogers Communications Canada Inc. (Patent) | Toronto | 30 d |
| Nov 4, 2019 | T-350-18 | Bristol-myers Squibb Canada Co. Et Al V. Apotex Inc. (Patent - Apixaban*) | Toronto | 10 d |
| Nov 4, 2019 | T-351-18 | Bristol-myers Squibb Canada Co. Et Al V. Apotex Inc. (Patent - Apixaban*) | Toronto | 10 d |
| Nov 18, 2019 | T-401-18 | Hoffmann-la Roche Limited Et Al V. Pfizer Canada Inc. (Patent - Trastuzumab*) | Toronto | 10 d |
| Nov 18, 2019 | T-402-18 | Hoffmann-la Roche Limited Et Al V. Pfizer Canada Inc. (Patent - Trastuzumab*) | Toronto | 10 d |
| Jan 6, 2020 | T-1471-17 | Pfizer Canada Inc. V. Genentech, Inc. Et Al (Patent - Bevacizumab*) | Toronto | 10 d |
| Jan 13, 2020 | T-666-18 | Bayer Inc. Et Al V. Jamp Pharma Corp. (Patent - Vardenafil*) | Montréal | 10 d |
| Jan 20, 2020 | T-741-18 | Amgen Inc. Et Al V. Pfizer Canada Inc. (Patent - Pegfilgrastim*) | Toronto | 10 d |
| Jan 27, 2020 | T-823-18 | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Rituximab*) | Toronto | 10 d |
| Jan 27, 2020 | T-824-18 | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Rituximab*) | Toronto | 10 d |
| Jan 27, 2020 | T-825-18 | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Rituximab*) | Toronto | 10 d |
| Jan 27, 2020 | T-826-18 | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Rituximab*) | Toronto | 10 d |
| Feb 3, 2020 | T-921-17 | Rovi Guides, Inc. Et Al V. Videotron G.p. Et Al (Patent) | Toronto | 20 d |
| Feb 3, 2020 | T-546-12 | Bauer Hockey Ltd. V. Sport Maska Inc. Et Al (Patent) | Montréal | 23 d |
| Feb 10, 2020 | T-929-18 | Galderma Canada Inc., Et Al. V. Apotex Inc. (Patent - Doxycycline*) | Ottawa | 10 d |
| Feb 17, 2020 | T-2004-13 | Sanofi Et Al V. Sandoz Canada Inc. (Patent - Clopidogrel*) | Toronto | 12 d |
| Feb 17, 2020 | T-2009-13 | Sanofi Et Al V. Pharmascience Inc. Et Al (Patent - Clopidogrel*) | Toronto | 12 d |
| Feb 24, 2020 | T-229-18 | Varco I/p Et Al V. Coil Solutions, Inc. (Patent) | Toronto | 10 d |
| Mar 2, 2020 | T-1349-17 | Wi-lan, Inc. V. Lg Electronics, Inc. Et Al (Patent) | Toronto | 15 d |
| Mar 2, 2020 | T-1163-18 | Biogen Canada Inc Et Al V. Taro Pharmaceuticals Inc (Patent - FAMPRIDINE*) | Toronto | 10 d |
| Mar 2, 2020 | T-1416-18 | Biogen Canada Inc. And Others V. Apotex Inc. (Patent - Fampridine*) | Toronto | 10 d |
| Mar 16, 2020 | T-1575-18 | Bristol-myers Squibb Canada Co. Et Al V. Teva Canada Limited (Patent - Apixaban*) | Toronto | 10 d |
| Mar 30, 2020 | T-1527-18 | Celgene Inc.et Al V. Natco Pharma Inc. (Patent - Lenalidomide*) | Toronto | 10 d |
| Mar 30, 2020 | T-1529-18 | Celgene Inc. Et Al V. Natco Pharma Inc. (Patent - Lenalidomide*) | Toronto | 10 d |
| Apr 20, 2020 | T-1069-14 | Jason Swist Et Al V. Meg Energy Corp. (Patent) | Toronto | 10 d |
| Apr 20, 2020 | T-1416-18 | Biogen Canada Inc. And Others V. Apotex Inc. (Patent - Fampridine*) | Toronto | 5 d |
| Apr 20, 2020 | T-1503-18 | Amgen Inc. Et Al. V. Sandoz Canada Inc. (Patent - Pegfilgrastim*) | Toronto | 10 d |
| May 4, 2020 | T-569-17 | J.r. Simplot Company V. Mccain Foods Ltd. V. Simplot Canada (ii) Limited (Trade Mark) | Ottawa | 7 d |
| May 11, 2020 | T-311-12 | Bauer Hockey Ltd. V. Sport Maska Inc. Dba Reebok-ccm Hockey (Trade Mark) | Montréal | 13 d |
| Jun 8, 2020 | T-1692-18 | Cubist Pharmaceuticals Llc Et Al V. Teva Canada Limited (Patent - Daptomycin*) | Toronto | 10 d |
| Jun 22, 2020 | T-1768-18 | Bayer Inc. Et Al V. Apotex Inc. (Patent) | Toronto | 14 d |
| Sep 14, 2020 | T-1960-18 | Bayer Inc. And Bayer Intellectual Property Gmbh V. Teva Canada Lmt. (Patent - Rivaroxaban*) | Ottawa | 10 d |
| Oct 19, 2020 | T-1004-18 | Akebia Therapeutics, Inc. V. Fibrogen, Inc. (Patent) | Toronto | 12 d |
| Nov 30, 2020 | T-1184-17 | Merck Sharp & Dohme Corp.et Al V. Wyeth Llc (Patent - Pneumococcal*) | Toronto | 10 d |
| Jan 18, 2021 | T-151-16 | Angelcare Development Inc. Et Al. V. Munchkin, Inc Et Al. (Patent) | Montréal | 40 d |
| Feb 8, 2021 | T-1133-18 | Merck Sharp & Dohme Corp. Et Al V. Glaxosmithkline Biologicals S.a. (Patent) | Toronto | 15 d |
Return to top.
Scheduled Judicial Review Hearings
| Date | File No. | Name | Type | Location | Length |
| Jan 14, 2019 | T-1195-18 | Canada Bread Company, Limited V Dr. Smood Aps | Trade Mark Opposition | Montréal | 2 h |
| Feb 4, 2019 | T-834-17 | Valeant Canada Lp/valeant Canada S.e.c. V. Generic Partners Canada Inc Et Al - Metformin* | S. 18.1 Patented Medicines (Notice of Compliance) Regulations | Toronto | 3 d |
| Feb 20, 2019 | T-1396-18 | Fmc Corporation V. Agc | Patent - Correction of Register | Montréal | 30 m |
| Feb 26, 2019 | T-573-18 | Justin Philip Abbott V. Canada (attorney General) Et Al. | S. 18.1 Application for Judicial Review (Aboriginal Law) | Ottawa | 1 d |
| Mar 5, 2019 | T-920-17 | Whirlpool Canada Lp V. Alliance Laundry Systems Llc | Trade Mark - Passing Off | Toronto | 1 d |
| Mar 20, 2019 | T-442-18 | C.c. Jentsch Cellars Inc. V. O'rourke Family Vineyards Ltd. Et Al | S. 18.1 Application for Judicial Review | Vancouver | 2 d |
| Apr 29, 2019 | T-1661-17 | Janssen Inc. Et Al V. Apotex Inc. Et Al - Abiraterone* | S. 18.1 Patented Medicines (Notice of Compliance) Regulations | Toronto | 4 d |
| May 13, 2019 | T-1034-17 | Endo Ventures Ltd. Et Al V. Apotex Inc. Et Al - Tapentadol* | S. 18.1 Patented Medicines (Notice of Compliance) Regulations | Toronto | 4 d |
| May 21, 2019 | T-1620-17 | Dr. David Kattenburg V. Agc | S. 18.1 Application for Judicial Review | Ottawa | 2 d |
| May 27, 2019 | T-1670-17 | Astrazeneca Canada Inc. Et Al. V. Apotex Inc. Et Al. - Ticagrelor* | S. 18.1 Patented Medicines (Notice of Compliance) Regulations | Toronto | 5 d |
| May 27, 2019 | T-1672-17 | Astrazeneca Canada Inc. Et Al. V. Apotex Inc. Et Al. - Ticagrelor* | S. 18.1 Patented Medicines (Notice of Compliance) Regulations | Toronto | 5 d |
| Sep 23, 2019 | T-1143-17 | Celgene Inc. Et Al V. Dr. Reddy's Laboratories Ltd. Et Al - Lenalidomide* | S. 18.1 Patented Medicines (Notice of Compliance) Regulations | Toronto | 2 d |
| Sep 23, 2019 | T-1669-17 | Celgene Inc. Et Al V. Dr. Reddy's Laboratories Ltd. Et Al - Lenalidomide* | S. 18.1 Patented Medicines (Notice of Compliance) Regulations | Toronto | 2 d |
| Sep 30, 2019 | T-1143-17 | Celgene Inc. Et Al V. Dr. Reddy's Laboratories Ltd. Et Al - Lenalidomide* | S. 18.1 Patented Medicines (Notice of Compliance) Regulations | Toronto | 4 d |
| Sep 30, 2019 | T-1669-17 | Celgene Inc. Et Al V. Dr. Reddy's Laboratories Ltd. Et Al - Lenalidomide* | S. 18.1 Patented Medicines (Notice of Compliance) Regulations | Toronto | 4 d |
Return to top.
Scheduled IP Appeals
| Date | File No. | Name | Type | Location | Length |
| Jan 10, 2019 | A-94-18 | Seara Alimentos Ltda. V. Amira Enterprises Inc. | Appeal (S.27 - Final) - Trade-marks Act | Ottawa | 2 h |
| Jan 10, 2019 | A-95-18 | Seara Alimentos Ltda. V. Amira Enterprises Inc. | Appeal (S.27 - Final) - Trade-marks Act | Ottawa | 2 h |
| Jan 14, 2019 | A-69-18 | Tetra Tech Eba Inc. V. Georgetown Rail Equipment Company | Appeal (S.27 - Final) - Patent Act [from T-896-15 - Patent Infringement] | Toronto | 4 h |
| Jan 17, 2019 | A-385-17 | The Attorney General Of Canada V. Galderma Canada Inc. Et Al. - Adapalene* | Appeal (S.27 - Final) - Patent Act [from T-83-17 - S. 18.1 Application for Judicial Review] | Toronto | 4 h |
* Medicinal ingredients are based on automated analysis and should not be relied upon.
Return to top.